Russell Anderson
Family Medicine · Ithaca, MINPI 1972578862
Payments from drug & device makers
Across 95 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$272
- Novo Nordisk$245
- AbbVie$230
- Pfizer$120
- Merck$108
- Bayer$72
- plus $666 from 18 others
What the payments were for
- Food & beverage$1,713100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 13 | $272 |
| Novo Nordisk | 13 | $245 |
| AbbVie(2 entities) | 10 | $230 |
| Pfizer | 8 | $120 |
| Merck | 10 | $108 |
| Bayer | 3 | $72 |
| Amgen | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| GSK | 4 | $61 |
| Novartis | 4 | $57 |
| Johnson & Johnson | 2 | $52 |
| Sanofi-aventis U.S. LLC | 4 | $48 |
| Neurelis, Inc. | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 1 | $37 |
| Boehringer Ingelheim | 2 | $33 |
| Mylan Specialty L.p. | 2 | $30 |
| Alkermes, Inc. | 1 | $27 |
| AstraZeneca | 2 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,713 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 597 | $170,344 |
| TrulicityDulaglutide | 156 | $167,340 |
| JanuviaSitagliptin Phosphate | 145 | $83,808 |
| NuplazidPimavanserin Tartrate | 18 | $66,092 |
| JardianceEmpagliflozin | 87 | $65,387 |
| NuedextaDextromethorphan Hbr/Quinidine | 55 | $39,140 |
| Breo ElliptaFluticasone/Vilanterol | 74 | $35,456 |
| XareltoRivaroxaban | 75 | $29,764 |
| MounjaroTirzepatide | 24 | $27,512 |
| RybelsusSemaglutide | 40 | $23,713 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $23,560 |
| Invega SustennaPaliperidone Palmitate | 14 | $22,750 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $22,313 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 158 | $20,804 |
| Atorvastatin Calcium | 1,522 | $18,467 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $272 | $194,852180 claims |
| PfizerEliquis | $120 | $170,344597 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta, Combivent Respimat | $33 | $93,353131 claims |
| MerckJanuvia | $108 | $83,808145 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta | $61 | $66,017131 claims |
| Johnson & JohnsonXarelto, Invega Sustenna, Risperdal Consta | $52 | $62,940105 claims |
| Novo NordiskRybelsus, Ozempic | $245 | $38,46256 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort | $26 | $35,82972 claims |
| AbbVieCreon, Linzess | $230 | $27,953103 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $63 | $16,18620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Ithaca
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
- Rhonda MejeurGrand Rapids$493K
- Steve LasaterSaint Johns$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.